Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Finished Goods (2020 - 2025)

Historic Finished Goods for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $19.6 million.

  • Maravai Lifesciences Holdings' Finished Goods fell 1479.39% to $19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.6 million, marking a year-over-year decrease of 1479.39%. This contributed to the annual value of $23.1 million for FY2024, which is 1898.45% up from last year.
  • Maravai Lifesciences Holdings' Finished Goods amounted to $19.6 million in Q3 2025, which was down 1479.39% from $19.7 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Finished Goods registered a high of $23.1 million during Q4 2024, and its lowest value of $6.3 million during Q2 2021.
  • Moreover, its 5-year median value for Finished Goods was $11.5 million (2021), whereas its average is $14.4 million.
  • Its Finished Goods has fluctuated over the past 5 years, first plummeted by 2615.56% in 2022, then surged by 18576.53% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Finished Goods (Quarter) stood at $10.4 million in 2021, then fell by 26.16% to $7.7 million in 2022, then surged by 151.15% to $19.4 million in 2023, then rose by 18.98% to $23.1 million in 2024, then dropped by 15.02% to $19.6 million in 2025.
  • Its Finished Goods stands at $19.6 million for Q3 2025, versus $19.7 million for Q2 2025 and $22.7 million for Q1 2025.